How to Win!
Over the past 22 years we have learned how to beat the insurance companies and maximize our clients recoveries. We amass a legal team! We combined our successful talents and expertise with that of other top trial attorneys from around the country to give you a legal team with proven success for the same cost as having one lawyer.We Fight and You Win.
Results!
We have represented over 10,000 clients and recovered millions of dollars on their behalf. We take each case seriously. We are paid only when you get results!Here are just some of our successses
Free Legal Consultations.
Our personal injury lawyer team provides you with a legal consultation at no cost to ensure you know what to expect. If you have recently been in injured, caused by the negligence of another, consult with an attorney now.
Medical Malpractice
Mistakes caused by medical malpractice can be both traumatic and confusing. Often, there is little or no recourse for victims of medical malpractice or their families. We will vigorously investigate your claim. Contact an attorney to ensure your rights are protected.
Vioxx Injuries
The arthritis drug Vioxx, manufactured by Merck & Co., was recently pulled from the market because of data showing increased risk of heart attack and stroke associated with the drug. If you or someone you know have has a stroke or heart attack that may be related to the prescription drug Vioxx, consult with an attorney.
Nursing Home Abuse
We all want to be able to trust that our loved ones are safe and cared for when residing in a nursing home, but we have to watch out for signs of neglect or abuse. Consult with an attorney if you suspect mistreatment of a nursing home resident.
Drug Litigation
Prescription pharmaceuticals are often available to the public before potential risks are discovered. If you believe you are the victim of a dangerous prescription drug, consult with a drug litigation attorney.
Personal Injury News
- Consumer Advocacy Group Points to Risks of Meridia and Urges an FDA Ban The consumer advocacy group Public Citizen is petitioning the government to ban the popular weight loss pill Meridia. A recent 10,000 patient study, also known as the SCOUT study, showed that a higher risk of heart attack, stroke, and death are associated with the drug. Meridia is used by about 250,000 people, and it is prescribed to treat obesity by acting as an appetite suppressant. The FDA had previously rejected a petition by Public Citizen in 2002 to ban the drug, stating that it wanted to wait until the 10,000 patient study was completed. Public Citizen stated that 84 deaths have been associated with Meridia as of June 2009. Speaking on behalf of the group, Dr. Sidney Wolfe stated in a letter to the FDA, “We would hope the science behind the results seen in this study would mandate the only appropriate FDA action to protect the public health: immediate removal of ‘Meridia’ from the market.” Although the FDA has not issued a warning yet, a decision ....
- FDA Reminds Health Professionals of Serious Risks of Birth Defects from Depakote The FDA recently reminded healthcare professionals and patients about the increased risk of severe birth defects, including spinal defects, severe facial defects, and heart defects, associated with the drug Depakote. Depakote is commonly used to treat bipolar disorder, and has also been used to treat epilepsy, major depressive disorder, and migraine headaches. The FDA letter to healthcare professionals, dated December 3, 2009, was not the first warning regarding Depakote and birth defects. In October 2006, the FDA issued a black box warning regarding these exact dangers of Depakote. The recent letter serves as a reminder to healthcare professionals that Depakote, and other drugs containing valproic acid and divalproex sodium, should only be used for pregnant women if it is essential to their health. Depakote has especially been noted for leading to an increased risk of the birth defect spinal bifida. In the general population, spinal bifida occurs in fewer than one in one thousand ....
- Gadolinium-based MRI Drugs Pose Serious Health Risks BusinessWeek recently reported that some drugs used for MRI imaging may be riskier for patients with pre-existing kidney issues than previously believed. These drugs are all gadolinium-based, and include Omniscan, Magnevist, and Optimark. Some major hospitals had already ceased use of Omniscan when reports came out in 2006 that its use may lead to an increased risk of developing a condition called nephrogenic systemic fibrosis. Nephrogenic systemic fibrosis (NSF) is a rare, but potentially fatal disease. In May 2006, Danish medical regulators issued a warning that patients in Denmark and Austria with pre-existing kidney issues had suffered NSF after undergoing an MRI. The warning stated that the dye used to make MRI images clearer contributed to the development of NSF in these patients. Researchers in the U.S. and Europe subsequently found that gadolinium-based drugs have a higher risk of NSF than other drugs used for MRIs. The newest development over this controversy is that the FDA ....
- Thousand File Suit Against Bayer for Increased Risks of Taking Yaz The Washington Times reported recently that Bayer, the maker of the popular birth control Yaz, is currently facing thousands of lawsuits regarding the safety of the drug. The lawsuits were filed due to Yaz’sincreased risk of blood clots to users. This increased risk has led to serious injuries such as heart attacks, strokes and gallbladder disease for many women. In August, a study published in the British Medical Journal found evidence that Yaz, and its predecessor Yasmin, led to a higher risk of blood clots than other forms of birth control. A generic form of the birth control, Ocella, may lead to this increased risk of blood clots as well. The three drugs, Yaz, Yasmin, and Ocella, contain drospirenone, which is blamed for the increased risk of blood clots. Many clients pursuing cases against Bayer have no history of problems with blood clotting. The FDA issued a letter to Bayer last year, telling it to cease misleading advertising for Yaz. At the time, Bayer was running ....
- Recall of Dangerous Drop-Side Cribs On November 23, 2009, the Consumer Product Safety Commission recalled 2.1 million Stork Craft drop-side cribs. The recall occurred due to the growing concern about a defect in the crib’s drop-slide feature, which allows the crib’s gate to slide up and down. This defect can lead to the plastic hardware of the drop-side breaking, which may cause one of the corners of the crib to detach. Due to this problem, infants may become stuck in the space between the side of the crib and the mattress. More than 1.2 million of these cribs have been sold in the U.S over the past sixteen years. So far, the safety commission has reported 110 incidents relating to this defect, with at least four infants dying from being stuck in the gates of the crib. CBS Evening News reported recently that over the past decade, this crib has been blamed for dozens of infant deaths. Some safety advocates have urged federal regulators to create tougher standards for manufacturers of the drop-side crib. Some ....
The information provided does not constitute legal advice nor does it constitute an attorney client agreement. You are not considered a client until we have accepted your case and a retainer is signed. Read our full disclaimer.